Cargando…
New developments in the treatment of partial-onset epilepsy
Although most people presenting with partial-onset seizures will achieve control with antiepileptic medication, a considerable minority will have difficult-to-treat epilepsy that is resistant to existing medication. Over the last few years, a large number of new antiepileptic drugs have been develop...
Autores principales: | Besag, Frank MC, Patsalos, Philip N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477926/ https://www.ncbi.nlm.nih.gov/pubmed/23093905 http://dx.doi.org/10.2147/NDT.S25099 |
Ejemplares similares
-
Clinical efficacy of perampanel for partial-onset and primary generalized tonic–clonic seizures
por: Besag, Frank MC, et al.
Publicado: (2016) -
Perampanel: What is its Place in the Management of Partial Onset Epilepsy?
por: Ledingham, David R. M., et al.
Publicado: (2013) -
Epilepsy in patients with autism: links, risks and treatment challenges
por: Besag, Frank MC
Publicado: (2017) -
New developments in the management of partial-onset epilepsy: role of brivaracetam
por: Coppola, Giangennaro, et al.
Publicado: (2017) -
New drug classes for the treatment of partial onset epilepsy: focus on perampanel
por: Shih, Jerry J, et al.
Publicado: (2013)